OncoTherapy Science, Inc.
Status: Publicly traded
Direct answer
OncoTherapy Science, Inc. is publicly traded on JPX under the ticker 4564.T.
OncoTherapy Science, Inc. engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan. Its development pipeline includes OTS167, a small molecular compound that targets the maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase...
Can you invest in OncoTherapy Science, Inc.?
Yes. OncoTherapy Science, Inc. trades publicly on JPX as 4564.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for OncoTherapy Science, Inc.
Detailed equity research is provided by MarketSnap.